Cargando…
Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease
There is an urgent need for the identification of Alzheimer's disease (AD) biomarkers. Studies have now suggested the promising use of associations with blood metabolites as functional intermediate phenotypes in biomedical and pharmaceutical research. The aim of this study was to use lipidomics...
Autores principales: | Proitsi, P, Kim, M, Whiley, L, Pritchard, M, Leung, R, Soininen, H, Kloszewska, I, Mecocci, P, Tsolaki, M, Vellas, B, Sham, P, Lovestone, S, Powell, J F, Dobson, R J B, Legido-Quigley, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312824/ https://www.ncbi.nlm.nih.gov/pubmed/25585166 http://dx.doi.org/10.1038/tp.2014.127 |
Ejemplares similares
-
Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer’s Disease
por: Kim, Min, et al.
Publicado: (2017) -
Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer’s Disease
por: Leung, Rufina, et al.
Publicado: (2013) -
Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis
por: Proitsi, Petroula, et al.
Publicado: (2014) -
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
por: Whiley, Luke, et al.
Publicado: (2021) -
Deep Sequencing of the Nicastrin Gene in Pooled DNA, the Identification of Genetic Variants That Affect Risk of Alzheimer's Disease
por: Lupton, Michelle K., et al.
Publicado: (2011)